stat3 inhibitor sta 21 (Santa Cruz Biotechnology)
Santa Cruz Biotechnology is a verified supplier 
96
Structured Review
Santa Cruz Biotechnology
stat3 inhibitor sta 21
Stat3 Inhibitor Sta 21, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 4469 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sta-21/Stat3/pm39487455-81-3-8
Average 96 stars, based on 4469 article reviews
Stat3 Inhibitor Sta 21, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 4469 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sta-21/Stat3/pm39487455-81-3-8
Average 96 stars, based on 4469 article reviews
stat3 inhibitor sta 21 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Inhibition:Article Title: Blockade of STAT3 in T Cells Inhibits Germinal Center Reactions against Intranasal Allergens Article Snippet: For STAT3 inhibition experiments, mice were treated with intraperitoneal injections of 0.5 mg/kg Article Title: Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity Article Snippet: Sorted naïve B cells were treated with αCD40 (1 μg/mL), LPS (2 μg/mL), rIL-35 (50 ng/mL) with or without BCL6 and STAT inhibitors; Expressing:Article Title: Blockade of STAT3 in T Cells Inhibits Germinal Center Reactions against Intranasal Allergens Article Snippet: For STAT3 inhibition experiments, mice were treated with intraperitoneal injections of 0.5 mg/kg Article Title: Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity Article Snippet: Sorted naïve B cells were treated with αCD40 (1 μg/mL), LPS (2 μg/mL), rIL-35 (50 ng/mL) with or without BCL6 and STAT inhibitors; Marker:Article Title: Blockade of STAT3 in T Cells Inhibits Germinal Center Reactions against Intranasal Allergens Article Snippet: For STAT3 inhibition experiments, mice were treated with intraperitoneal injections of 0.5 mg/kg Article Title: Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity Article Snippet: Sorted naïve B cells were treated with αCD40 (1 μg/mL), LPS (2 μg/mL), rIL-35 (50 ng/mL) with or without BCL6 and STAT inhibitors; |